The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
CCR3 is a target for age-related macular degeneration diagnosis and therapy
Open accessAbstract
Age-related macular degeneration (AMD), a leading cause of blindness worldwide, is as prevalent as cancer in industrialized nations. Most blindness in AMD results from invasion of the retina by choroidal neovascularisation (CNV). Here we show that the eosinophil/mast cell chemokine receptor CCR3 is specifically expressed in choroidal neovascular endothelial cells in humans with AMD, and that despite the expression of its ligands eotaxin-1, -2 and -3, neither eosinophils nor mast cells are present in human CNV. Genetic or pharmacological targeting of CCR3 or eotaxins inhibited injury-induced CNV in mice. CNV suppression by CCR3 blockade was due to direct inhibition of endothelial cell proliferation, and was uncoupled from inflammation because it occurred in mice lacking eosinophils or mast cells, and was independent of macrophage and neutrophil recruitment. CCR3 blockade was more effective at reducing CNV than vascular endothelial growth factor A (VEGF-A) neutralization, which is in clinical use at present, and, unlike VEGF-A blockade, is not toxic to the mouse retina. In vivo imaging with CCR3-targeting quantum dots located spontaneous CNV invisible to standard fluorescein angiography in mice before retinal invasion. CCR3 targeting might reduce vision loss due to AMD through early detection and therapeutic angioinhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated CCL11 in the plasma and cerebrospinal fluid seen in aging mice and humans are associated with declining neurogenesis, neurodegenerative disease, and cognitive decline and may contribute to driving neovascularisation in AMD via interaction with CCR3 [1, 93, 123].”
From Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain (2022) · cites this paper as [1]
In the citing paper
“Elevated CCL11 in the plasma and cerebrospinal fluid seen in aging mice and humans are associated with declining neurogenesis, neurodegenerative disease, and cognitive decline and may contribute to driving neovascularisation in AMD via interaction with CCR3 [1, 93, 123].”
From Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain (2022) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,162
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,661
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
Genes Expressed in Human Tumor Endothelium
Croix, B. S., Rago, C., Velculescu, V. E., Traverso, G., Romans, K. E., Montgomery, E. A., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B., et al. (2000) · Science · doi:10.1126/science.289.5482.1197 · Cited by 1,859
Rothenberg, M. E., & Hogan, S. P. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090720 · Cited by 1,356
Self-citationGene Expression Profiles in Normal and Cancer Cells
Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.276.5316.1268 · Cited by 1,186
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies
Ambati, J., Ambati, B. K., Yoo, S. H., Ianchulev, S., & Adamis, A. P. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00030-4 · Cited by 959
Self-citationSequence- and target-independent angiogenesis suppression by siRNA via TLR3
Kleinman, M. E., Yamada, K., Takeda, A., Chandrasekaran, V., Nozaki, M., Baffi, J., Albuquerque, R., Yamasaki, S., Itaya, M., Pan, Y., et al. (2008) · Nature · doi:10.1038/nature06765 · Cited by 939
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 260
Nagai, N., Ju, M., Izumi‐Nagai, K., Robbie, S. J., Bainbridge, J. W., Gale, D. C., Pierre, E., Krauss, A. H. ‐., Adamson, P., Shima, D. T., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.04.029 · Cited by 29
Effects of posterior vitreous detachment on aqueous humour levels of VEGF and inflammatory cytokines
Takahashi, H., Nomura, Y., Tan, X., Fujino, Y., Kawashima, H., & Yanagi, Y. (2015) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-306051 · Cited by 29
Choroidal Mast Cells in Retinal Pathology
Bousquet, E., Zhao, M., Thillaye-Goldenberg, B., Lorena, V., Castañeda, B., Naud, M. C., Bergin, C., Besson-Lescure, B., Béhar‐Cohen, F., & de Kozak, Y. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.04.002 · Cited by 29
Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety
Tang, F., LeBlanc, M. E., Wang, W., Liang, D., Chen, P., Chou, T.-H., Tian, H., & Li, W. (2019) · Angiogenesis · doi:10.1007/s10456-019-09662-4 · Cited by 29
Nielsen, M. K., Subhi, Y., Molbech, C. R., Falk, M. K., Nissen, M. H., & Sørensen, T. L. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.4.28 · Cited by 29
Copy Number Variations in Candidate Genes in Neovascular Age-Related Macular Degeneration
Liu, M. M., Agrón, E., Chew, E. Y., MEYERLE, C. B., Ferris, F. L., Chan, C., & Tuo, J. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6735 · Cited by 28
Emerging therapeutic approaches in the management of retinal angiogenesis and edema
Truong, A., Wong, T. Y., & Khachigian, L. M. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0709-z · Cited by 27
Giacalone, J. C., Miller, M. J., Workalemahu, G., Reutzel, A. J., Ochoa, D., Whitmore, S. S., Stone, E. M., Tucker, B. A., & Mullins, R. F. (2018) · Microvascular Research · doi:10.1016/j.mvr.2018.12.002 · Cited by 28
Deng, H. X., Li, T., Xie, J., Huang, N., Gu, Y., & Zhao, J. (2013) · Dyes and Pigments · doi:10.1016/j.dyepig.2013.06.037 · Cited by 28
Or, C., Cui, J. Z., Matsubara, J. A., & Forooghian, F. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-303355 · Cited by 28
Hirasawa, M., Takubo, K., Osada, H., Miyake, S., Toda, E., Endo, M., Umezawa, K., Tsubota, K., Oike, Y., & Ozawa, Y. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.710186 · Cited by 28
(1987) · PubMed · Cited by 28
Nanomedicine in the application of uveal melanoma
You, S., Luo, J., Grossniklaus, H. E., Gou, M., Meng, K., & Zhang, Q. (2016) · International Journal of Ophthalmology · doi:10.18240/ijo.2016.08.20 · Cited by 27
Salehi-Had, H., Roh, M., Giani, A., Hisatomi, T., Nakao, S., Kim, I. K., Gragoudas, E. S., Vavvas, D. G., Guccione, S., & Miller, J. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018864 · Cited by 28
AAV2 Delivery of Flt23k Intraceptors Inhibits Murine Choroidal Neovascularization
Zhang, X., Das, S. K., Passi, S. F., Uehara, H., Bohner, A. D., Chen, M., Tiem, M., Archer, B. J., & Ambati, B. K. (2014) · Molecular Therapy · doi:10.1038/mt.2014.199 · Cited by 27
Self-citationDefence against oxidative damage
Cruz‐Guilloty, F., & Perez, V. L. (2011) · Nature · doi:10.1038/478042a · Cited by 27
Intravenous immune globulin suppresses angiogenesis in mice and humans
Yasuma, R., Cicatiello, V., Mizutani, T., Tudisco, L., Kim, Y., Tarallo, V., Bogdanovich, S., Hirano, Y., Kerur, N., Li, S., et al. (2016) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2015.2 · Cited by 26
Self-citationOral Metformin Inhibits Choroidal Neovascularization by Modulating the Gut-Retina Axis
Zhang, J. Y., Xiao, J. F., Xie, B., Barba, H., Boachie-Mensah, M., Shah, R. N., Nadeem, U., Spedale, M., Dylla, N. P., Lin, H., et al. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.15.21 · Cited by 25
Mäkikallio, K., Kaukola, T., Tuimala, J., Kingsmore, S. F., Hallman, M., & Ojaniemi, M. (2012) · Cytokine · doi:10.1016/j.cyto.2012.07.008 · Cited by 25
Stewart, M. W., Garg, S., Newman, E., Jeffords, E., Konopińska, J., Jackson, S., Sikorski, B. L., & Rawner, E. (2022) · Retina · doi:10.1097/iae.0000000000003446 · Cited by 25
Semaphorin 3E Inhibits House Dust Mite–Induced Angiogenesis in a Mouse Model of Allergic Asthma
Tatari, N., Movassagh, H., Shan, L., Koussih, L., & GOUNNI, A. S. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.01.008 · Cited by 24
Integrative Pathway-Centric Modeling of Ventricular Dysfunction after Myocardial Infarction
Azuaje, F. J., Devaux, Y., & Wagner, D. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009661 · Cited by 24
Molecular Imaging of Retinal Disease
Capozzi, M. E., Gordon, A. Y., Penn, J. S., & Jayagopal, A. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0279 · Cited by 23
Brivio, D., Zygmanski, P., Arnoldussen, M. E., Hanlon, J., Chell, E. W., Sajo, E., Makrigiorgos, G. M., & Ngwa, W. F. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/24/9203 · Cited by 23
CCL24 Signaling in the Tumor Microenvironment
Lim, S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-62658-7_7 · Cited by 23
Dai, C., Waduge, P., Ji, L., Huang, C., He, Y., Tian, H., Zuniga-Sanchez, E., Bhatt, A. R., Pang, I., Su, G., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04111-2 · Cited by 23
Shiraya, T., Kato, S., Araki, F., Ueta, T., Miyaji, T., & Yamaguchi, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174340 · Cited by 23
Kaneko, H., Ye, F., Ijima, R., Kachi, S., Kato, S. X., Nagaya, M., Higuchi, A., & Terasaki, H. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12737 · Cited by 23
Self-citationSingh, M., & Tyagi, S. C. (2017) · International Journal of Ophthalmology · doi:10.18240/ijo.2017.05.06 · Cited by 22
Vascular Inflammation Risk Factors in Retinal Disease
Soto, I., Krebs, M. P., Reagan, A. M., & Howell, G. R. (2019) · Annual Review of Vision Science · doi:10.1146/annurev-vision-091517-034416 · Cited by 24
Quantum Dots in Ophthalmology: A Literature Review
Sarwat, S., Stapleton, F. J., Willcox, M. D. P., & Roy, M. (2019) · Current Eye Research · doi:10.1080/02713683.2019.1660793 · Cited by 22
Joo, J.-H., Kim, H., Shin, J.-H., & Moon, S. W. (2021) · BMC Ophthalmology · doi:10.1186/s12886-021-02152-6 · Cited by 21
Yang, D., Li, M., Liu, P., Song, H., Zhao, Y., & Shi, J. (2014) · Acta Oto-Laryngologica · doi:10.3109/00016489.2014.880795 · Cited by 21
Asosingh, K., Vasanji, A., Tipton, A. R., Queisser, K. A., Wanner, N., Janocha, A. J., Grandon, D., Anand‐Apte, B., Rothenberg, M. E., Dweik, R. A., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1500770 · Cited by 22
Self-citationZayed, M., Iohara, K., Watanabe, H., & Nakashima, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-65301-9 · Cited by 20
Zhou, T., Yang, Z., Ni, B., Zhou, H. Q., Xu, H., Lin, X., Li, Y., Liu, C., Ju, R., Ge, J., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05433-0 · Cited by 20
Secretogranin III as a novel target for the therapy of choroidal neovascularization
LeBlanc, M. E., Wang, W., Ji, Y., Tian, H., Liu, D., Zhang, X., & Li, W. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.01.009 · Cited by 20
Milligram Production and Biological Activity Characterization of the Human Chemokine Receptor CCR3
Wang, M., Ge, B., Li, R., Wang, X., Lao, J., & Huang, F. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065500 · Cited by 19
Perna, A. F., Russo, L., D’Esposito, V., Formisano, P., Bruzzese, D., Vigorito, C., Coppola, A., Lombari, P., Russo, D., & Ingrosso, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136875 · Cited by 21
Interleukin-6 receptor blockade suppresses subretinal fibrosis in a mouse model.
Cui, W., Zhang, H., & Liu, Z.-L. (2014) · International Journal of Ophthalmology · doi:10.3980/j.issn.2222-3959.2014.02.02 · Cited by 23
Chemokine Receptor Profiles of T Cells in Patients with Age-Related Macular Degeneration
Choi, Y. J., Lim, D., Byeon, S. H., Shin, E., & Chung, H. (2022) · Yonsei Medical Journal · doi:10.3349/ymj.2022.63.4.357 · Cited by 18
Mast cells are present in the choroid of the normal eye in most vertebrate classes
McMenamin, P. G., & Polla, E. (2013) · Veterinary Ophthalmology · doi:10.1111/vop.12035 · Cited by 18
Hinnerskov, J. M. V., Nielsen, M. K., Thomsen, A. K., Steffensen, M. A., Honoré, B., Vorum, H., Nissen, M. H., & Sørensen, T. L. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.1.5 · Cited by 17
Kuny, S., Gaillard, F. P., & Sauvé, Y. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8418 · Cited by 17
New Therapies of Neovascular AMD—Beyond Anti-VEGFs
Yerramothu, P. (2018) · Vision · doi:10.3390/vision2030031 · Cited by 21
So, J.-B., Silver, P., Jittayasothorn, Y., Mattapallil, M., Chan, C.-C., Horai, R., & Caspi, R. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102507 · Cited by 18
Pan, Y., Iejima, D., Nakayama, M., Suga, A., Noda, T., Kaur, I., Das, T., Chakrabarti, S., Guymer, R. H., DeAngelis, M. M., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100456 · Cited by 15
Self-citationSelectively targeting disease‐restricted secretogranin III to alleviate choroidal neovascularization
Ji, L., Waduge, P., Hao, L., Kaur, A., Wan, W., Wu, Y. L., Tian, H., Zhang, J., Webster, K. A., & Li, W. (2021) · The FASEB Journal · doi:10.1096/fj.202101085rr · Cited by 15
Falk, M. K., Singh, A., Faber, C., Nissen, M. H., Hviid, T. V. F., & Sørensen, T. L. (2014) · BMC Ophthalmology · doi:10.1186/1471-2415-14-22 · Cited by 15
Aquaporins: Novel Targets for Age-Related Ocular Disorders
Patil, R. V., Wang, H., Sharif, N. A., & MITRA, A. K. (2017) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2017.0024 · Cited by 15
Emerging therapies targeting eosinophil-mediated inflammation in chronic allergic conjunctivitis
Fernandez, A. D., Asbell, P. A., & Roy, N. S. (2022) · The Ocular Surface · doi:10.1016/j.jtos.2022.08.004 · Cited by 14
Balasubramanian, S. A., Kumar, K. K., & Baird, P. N. (2014) · Translational research · doi:10.1016/j.trsl.2014.04.005 · Cited by 13
Neovascularization: Ocular Diseases, Animal Models and Therapies
Cai, X., Sezate, S. A., & McGinnis, J. F. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0631-0_32 · Cited by 13
Wang, H., Han, X., Gambhir, D., Becker, S., Kunz, E., Liu, A. J., & Hartnett, M. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157748 · Cited by 13
Self-citationSun, T., Wei, Q., Gao, P., Zhang, Y., & Peng, Q. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s307657 · Cited by 12
Neutrophils in Ocular Diseases
Bammidi, S., Koontz, V., Gautam, P., Hose, S., Sinha, D., & Ghosh, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147736 · Cited by 12
Shimizu, H., Takayama, K., Yamada, K., Suzumura, A., Sato, T., Nishio, Y., Ito, M., Ushida, H., Nishiguchi, K. M., Takeuchi, M., et al. (2022) · Antioxidants · doi:10.3390/antiox12010045 · Cited by 11
Self-citationInhibitory effect of CCR3 signal on alkali-induced corneal neovascularization.
Zhou, W., Liu, G., Li, L.-B., Zhang, X., & Lu, P. (2012) · Europe PMC (PubMed Central) · doi:10.3980/j.issn.2222-3959.2012.03.01 · Cited by 11
Wang, Y., Gao, Y., Shi, H., Gao, R., Yang, J., Qu, Y., Hu, S., Zhang, J., Wang, J., Cao, J., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-023-01764-9 · Cited by 10
Profiling disease-selective drug targets: From proteomics to ligandomics
Waduge, P., Tian, H., Webster, K. A., & Li, W. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103430 · Cited by 10
Breaking barriers: insight into the pathogenesis of neovascular age-related macular degeneration
Hartnett, M. E., Wittchen, E. S., & Hartnett, M. E. (2011) · Eye and Brain · doi:10.2147/eb.s24951 · Cited by 10
Self-citationRetinal Fundus Imaging in Mouse Models of Retinal Diseases
Alex, A. F., Heiduschka, P., & Eter, N. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-080-9_3 · Cited by 10
Ijima, R., Kaneko, H., Ye, F., Takayama, K., Nagasaka, Y., Kataoka, K., Funahashi, Y., Iwase, T., Kachi, S., Kato, S. X., et al. (2015) · Translational Vision Science & Technology · doi:10.1167/tvst.4.2.6 · Cited by 9
Self-citationWang, Y., Rattner, A., Li, Z., Smallwood, P. M., & Nathans, J. (2025) · eLife · doi:10.7554/elife.107018 · Cited by 12
Novel Retinal Imaging Technologies
Li, Y., & Paulus, Y. M. (2017) · International Journal of Ophthalmology & Eye Science · doi:10.19070/2332-290x-1700010e · Cited by 8
Novel oral medications for retinal disease: an update on clinical development
DeBoer, C. M. T., Agrawal, R., & Rahimy, E. (2023) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000948 · Cited by 9
Genetic and Epigenetic Regulation in Age-Related Macular Degeneration
Wei, L., Chen, P., Lee, J. H., & Nussenblatt, R. B. (2013) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0b013e31829e2793 · Cited by 8
Shiraya, T., Kato, S., Araki, F., & Ueta, T. (2016) · Acta Ophthalmologica · doi:10.1111/aos.13232 · Cited by 8
Reichard, A., & Asosingh, K. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85110 · Cited by 8
Intraocular VEGF deprivation induces degeneration and fibrogenic response in retina
Xiao, M., Liu, Y., Wang, L., Liang, J., Wang, T., Zhai, Y., Yf, W., Liu, S., Liu, W., Luo, X., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901283rr · Cited by 8
Novel therapies for proliferative retinopathies
Martínez-Alejo, J. M., Baiza-Durán, L. M., & Quintana-Hau, J. D. D. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221140395 · Cited by 6
Ocular drug delivery for bioactive proteins
Yasukawa, T., Tabata, Y., Kimura, H., & Ogura, Y. (2011) · Expert Review of Ophthalmology · doi:10.1586/eop.11.66 · Cited by 7
Self-citationAMD Genetics in India: The Missing Links
Anand, A., Sharma, K., Sharma, S., Singh, R., Sharma, N. K., & Prasad, T. S. K. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00115 · Cited by 7
Bjerregaard, T., Nielsen, M. K., Molbech, C. R., Subhi, Y., & Sørensen, T. L. (2019) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2019-000307 · Cited by 7
Kong, S.-K., Kim, B., Uhm, T. G., Lee, W., Lee, G. R., Park, C., Lee, C., & Chung, I. Y. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203542 · Cited by 6
Development of Novel Drugs for Ocular Diseases: Possibilities for Individualized Therapy
Lai, T. Y. Y., Chen, L. J., Yam, G. H., Tham, C. C. Y., & Pang, C. P. (2010) · Personalized Medicine · doi:10.2217/pme.10.25 · Cited by 6
A Phage Display-Based Approach to Investigate Abnormal Neovessels of the Retina
Staniszewska, M. M., Gu, X., Romano, C., & Kazlauskas, A. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9690 · Cited by 6
Zarbin, M. A., Leary, J. F., Montemagno, C. D., Ritch, R. H., & Humayun, M. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00036-9 · Cited by 6
Ge, B., Wang, M., Li, J., Liu, J., & Huang, F. L. (2014) · Process Biochemistry · doi:10.1016/j.procbio.2014.12.001 · Cited by 6
Nanotechnology in Ophthalmology
Petrovic, N. T., Petrovic, M. J., Srećković, S., Jovanović, S., Todorović, D., & Vulovic, T. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-56979-6_11 · Cited by 5
Association of IL-4 gene polymorphism and age-related macular degeneration in Taiwanese adults
Sheu, S., Ger, L., Kuo, N.-W., Liu, N.-C., Wu, T., & Lin, M. (2012) · Taiwan Journal of Ophthalmology · doi:10.1016/j.tjo.2012.02.002 · Cited by 6
Kuwabara, Y., Katayama, A., Igarashi, T., 富山, 僚., Piao, H., Kaneko, R., Abe, T., 峯, 克., Akira, S., Orimo, H., et al. (2012) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2011.01100.x · Cited by 6
Editorial: Are all eotaxins created equal?
Pease, J. E., & Williams, T. J. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0413189 · Cited by 6
Assessing Eye Tracking for Continuous Central Field Loss Monitoring
Grootjen, J. W., Sipatchin, A., Wahl, S., Machulla, T., Chuang, L. L., & Kosch, T. (2023) · International Conference on Mobile and Ubiquitous Multimedia (MUM) · doi:10.1145/3626705.3627776 · Cited by 6
Analysis of CCR3 expression in corneal neovascularization in a murine model and human corneas
Haber, A., Polanía-Barón, E. J., Bolaños-Jiménez, R., Navas, A., Hernández, E. O. G., & Garfias, Y. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108076 · Cited by 5
Huang, X., Zhang, L., Fu, Y., Zhang, M., Yang, Q., & Peng, J. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1199922 · Cited by 5
Macrophages in age-related macular degeneration: a narrative review
Khademi, S., Yu, Z., Zhou, T., Song, B., & Xu, Z. (2024) · Aging advances. · doi:10.4103/agingadv.agingadv-d-24-00007 · Cited by 5
Chou, D. L., Gerriets, J. E., Schelegle, E. S., Hyde, D. M., & Miller, L. A. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.09.001 · Cited by 5
CCR3: Shedding New Light on a Dark Problem?
Mason, A. B., & Hoh, J. (2009) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjp011 · Cited by 5
Gene Therapy using SiRNA for Treatment of Ocular Neovascularization
Wang, C., Lu, D., & Chiang, C. (2010) · doi:10.6136/jms.2010.30(3).079 · Cited by 4
Recombinant sulfated CCR2 peptide trap reduces retinal degeneration in mice
Jung, S., Jin, S., Chae, J., Jo, G., Chung, H., Lyu, J., & Lee, J. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.08.002 · Cited by 4
Neroev, V. V., Balatskaya, N. V., Neroeva, N. V., Karmokova, A. G., Ryabina, M. V., & Kulikova, I. G. (2022) · Medical Immunology (Russia) · doi:10.15789/1563-0625-soc-2351 · Cited by 3
CCR3 Expression in Relation to Delayed Microbleeds in a Rat Model of Large Vessel Occlusion
Claypoole, S. M., Frank, J. A., Messmer, S. J., & Pennypacker, K. R. (2024) · Journal of Experimental Neurology · doi:10.33696/neurol.5.082 · Cited by 2
Retinal Fundus Imaging in Mouse Models of Retinal Diseases
Alex, A. F., Alnawaiseh, M., Heiduschka, P., & Eter, N. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8669-9_17 · Cited by 3
Oxidative Stress in the RPE and Its Contribution to AMD Pathogenesis: Implication of Light Exposure
Ozawa, Y. (2014) · Springer eBooks · doi:10.1007/978-4-431-54965-9_17 · Cited by 3
Evaluation of the self-eye examination method for health promotion
de Lima, M. A., do Nascimento, J. C., da Silva, A. B. R., Barros, L. M., Pagliuca, L. M. F., & Caetano, J. Á. (2018) · Revista da Escola de Enfermagem da USP · doi:10.1590/s1980-220x2017003803340 · Cited by 3
The Role of Inflammation in Age-Related Macular Degeneration
Harris, J. M., & Wu, D. M. (2025) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000578 · Cited by 2
Multi-characteristic opsin enabled vision restoration
Wright, W. W., Pradhan, S., Bhattacharya, S., Mahapatra, V., Tripathy, A., Gajjeraman, S., & Mohanty, S. K. (2017) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2257527 · Cited by 2
Investigating mechanisms of angiogenesis in health and disease using zebrafish models
Ali, Z. (2018) · Linköping University medical dissertations · doi:10.3384/diss.diva-153266 · Cited by 2
Metadata
- Authors
- Takeda, A., Baffi, J. Z., Kleinman, M. E., Cho, W. G., Nozaki, M., Yamada, K., Kaneko, H., Albuquerque, R. J. C., Dridi, S., Saito, K., Raisler, B. J., Budd, S. J., Geisen, P., Munitz, A., Ambati, B. K., Green, M. G., Ishibashi, T., Wright, J. D., Humbles, A. A., Gerard, C. J., Ogura, Y., Pan, Y., Smith, J. R., Grisanti, S., Hartnett, M. E., Rothenberg, M. E., & Ambati, J.
- Affiliations
- University of Kentucky (US)
- University of North Carolina at Chapel Hill (US)
- Cincinnati Children's Hospital Medical Center (US)
- University of Utah (US)
- Kyushu University (JP)
- Harvard University (US)
- Nagoya City University (JP)
- Oregon Health & Science University (US)
- University of Lübeck (DE)
- Corresponding author
- Ambati, Jayakrishna
- ORCID
- Venue
- Nature
- Published
- 2009-06-14
- Volume
- 460
- Issue
- 7252
- Pages
- 225-230
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2712122
- OpenAlex
- W1978268544
- Cited by
- 263
- References
- 49
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 10 · 2023: 8 · 2022: 18 · 2021: 11 · 2020: 12 · 2019: 11 · 2018: 10 · 2017: 20 · 2016: 22 · 2015: 14 · 2014: 20 · 2013: 22 · 2012: 22
- FWCI
- 23.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UNC Libraries
- Funders
- U.S. Department of Defense
- American Health Assistance Foundation
- International Retinal Research Foundation
- Research to Prevent Blindness
- Macula Vision Research Foundation
- E. Matilda Ziegler Foundation for the Blind
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Eye Institute (R01EY017950, R01EY018836, R01EY015422, EY018836, R01EY018350, EY018350, EY 010572, EY017011, R01EY017182, EY017182, EY017950, EY015130, R01EY017011, P30EY010572, EY015422)
- National Institute of Allergy and Infectious Diseases (R01AI039759, R37AI045898, AI 45898, AI039759)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK076893, DK076893)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- age-related macular degeneration, CCR3, choroidal neovascularization, eotaxin, eosinophils, mast cells, endothelial cell proliferation, anti-VEGF therapy, early diagnosis, quantum dot imaging, retinal neovascularization, blindness prevention, anti-angiogenic therapy
- MeSH terms
- Chemokine CCL26, Animals, Cell Movement, Cells, Cultured, Choroid, Disease Models, Animal, Humans, Inflammation, Leukocytes, Ligands, Macular Degeneration, Mice, Inbred C57BL, Retina, Chemokines, CC, Choroidal Neovascularization, Vascular Endothelial Growth Factor A, Endothelial Cells, Quantum Dots, Cell Proliferation, Mice, Receptors, CCR3, Chemokine CCL11, Chemokine CCL24
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
